Metabolic side effects of antipsychotic drugs
- Prosjektnummer
- 911537
- Ansvarlig person
- Silje Skrede
- Institusjon
- Helse Bergen HF
- Prosjektkategori
- Forskerutdanning - dr.grad
- Helsekategori
- Mental Health
- Forskningsaktivitet
- 5. Treatment Developement
Olanzapine, but not aripiprazole, weight-independently elevates serum triglycerides and activates lipogenic gene expression in female rats.
Int J Neuropsychopharmacol 2012 Mar;15(2):163-79. Epub 2011 aug 19
PMID: 21854679 - Inngår i doktorgradsavhandlingen
Lipid-lowering effects of tetradecylthioacetic Acid in antipsychotic-exposed, female rats: challenges with long-term treatment.
PLoS One 2012;7(11):e50853. Epub 2012 nov 30
PMID: 23226405 - Inngår i doktorgradsavhandlingen
Acute effects of orexigenic antipsychotic drugs on lipid and carbohydrate metabolism in rat.
Psychopharmacology (Berl) 2012 Feb;219(3):783-94. Epub 2011 jul 12
PMID: 21748251
Olanzapine-induced hyperphagia and weight gain associate with orexigenic hypothalamic neuropeptide signaling without concomitant AMPK phosphorylation.
PLoS One 2011;6(6):e20571. Epub 2011 jun 13
PMID: 21695181
Lipogenic effects of psychotropic drugs: focus on the SREBP system.
Front Biosci 2011;16():49-60. Epub 2011 jan 1
PMID: 21196158
Developing a rodent model for antipsychotic-induced metabolic adverse effects
- Disputert:
- april 2012
- Hovedveileder:
- VIdar Steen
Metabolic effects of antipsychotic drugs
- Disputert:
- oktober 2012
- Hovedveileder:
- Vidar Steen
eRapport er utarbeidet av Sølvi Lerfald og Reidar Thorstensen, Regionalt kompetansesenter for klinisk forskning, Helse Vest RHF, og videreutvikles av de fire RHF-ene i fellesskap, med støtte fra Helse Vest IKT
Alle henvendelser rettes til Faglig rapportering, Helse Vest